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ABSTRACT 
Developing countries suffer from a huge burden of neonatal sepsis. Neonatal mortality and long term sequelae or morbidity portends huge 
costs for the poor Nigerian economy.  We identified trends in bacterial agents implicated in neonatal sepsis and their antibiotic susceptibility 
profiles at the National Hospital Abuja over two periods of three years each a decade apart.  A retrospective study of bacterial agents of sepsis 
from 2013-2015 was carried out and this was compared to an already published study from the same hospital ten years  earlier(2002-2004) to 
determine changing trends using standard statistical methods.  
We identified a significant shift to predominance of gram positive organisms especially Staphylococcus aureus (59% vs 40%) as against the 
predominance of gram negative organisms especially Klebsiella pneumoniae (11% vs 44%) in the previous decade. Almost all antibiotics tested 
(92%) had reduced susceptibility in the later review compared to the former. 
Surveillance of bacterial agents of neonatal sepsis is vital for the detection of trends in causative organisms and their susceptibilities. This is 
important to direct empiric therapy and also to encourage implementation and monitoring of antibiotic stewardship programs.  
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RESUME 
Les pays en développement souffrent d’un énormefardeau de sepsisnéonatal. La mortaliténéonatale et les séquelles à long terme ou la 
morbidité annonce des coûts pour la pauvre économienigériane.  Nous avons identifié les tendances des agents bactériens impliqués dans le 
sepsisnéonatal et leurs profils de sensibilité aux antibiotiques à l’hôpital national d’Abuja sur deux périodes de trois ans chaque décennie à 
part. Uneétuderétrospective des agents bactériens de sepsis à partir de 2013 – 2015 a été réalisée et ceci a été comparé à une étude  déjà publiée 
du mêmehôpital dix ans plus tôt (2002 – 2004) pour déterminer les tendances changeantes en utilisant des méthodes statistiques standard. 
Nous avons identifié un changement significatif vers la prédominance des organismes gram négative, en particulier le Staphylococcus aureus 
(59% vs 40%) au contraire de la prédominance des organismes gram – négatifs, en particulier la Klebsiella pneumoniae (11% vs 44%)au cours de 
la décennieprécédente. 
La surveillance des agents bactériens du sepsisnéonatal est vitale pour la direction des tendances des organismes causatif set de leurs 
susceptibilités. Il est important de diriger la thérapie empirique et d’encourager la mise en œuvre et la surveillance des programmes 
d’intendance des antibiotiques. 
INTRODUCTION 
Neonatal sepsis causes significant morbidity and mortality 
worldwide especially in developing countries where the 
effects are often devastating for the baby, family and 
economy.  It is estimated that sub-Saharan Africa had 2.6 
million cases of serious bacterial infection in 2012, the 
highest for any WHO region with a case fatality of 14% (1). 
Mortality rates are high for neonatal sepsis and reports show 
that 17%- 41% of neonatal deaths in Nigeria are from sepsis 
(2-5).  
Geographical differences in bacterial agents responsible for 
sepsis occur. Group B Streptococcus for example is not often 
reported in developing countries including Nigeria but is the 
most common cause of sepsis in the developed world (6).  In 
Nigeria, the most common bacteria isolated from blood 
cultures of neonates include; S. aureus, E.coli, K. pneumoniae, 
S. aureus and P. aeruginosa (7-12).  
Empiric therapy is usually based on international guidelines 
or local antibiograms that are rarely reviewed in Nigeria. 
Sometimes pressure from commercial pharmaceutical 
company representatives may influence the choice of empiric 
therapy. Because changes do occur over time in the types of 
bacteria causing sepsis and their susceptibilities to different 
antibiotics, it is of vital importance that to effectively manage 
neonatal sepsis, surveillance and tailored strategies to fit the 




This study was aimed at assessing possible changes in the 
profile of organisms causing neonatal sepsis in NHA over a 
decade and also to detect changes in susceptibilities that 
have occurred over this time. The result would serve as a 
guide for modification of current empiric therapy choices 
and also provide a strong case for institution of efficient and 
effective infection control/antibiotic stewardship strategies.  
METHODS                                                                                                                                                                                                                
Neonatal blood cultures received at the medical 
microbiology laboratory of the National Hospital Abuja were 
reviewed for the periods 2002-2004 and 2013-2015.   While in 
the 2002-2004 period the Oxoid signal system (Oxoid USA, 
Inc., Columbia, Md.) was used to process blood cultures, in 
the later period, the BACTEC system (Becton Dickinson, 
Ireland) was used. Otherwise, all protocols were the same for 
the two periods under review. The 2013-2015 data were 
compared with an already analysed and published data from 
2002-2004 from the same laboratory. Paediatricians made the 
initial impression of sepsis based on clinical features in the 
neonate following which they collected 1-2mls of blood 
aseptically into culture bottles; Oxoid signal in 2002-2004 as 
previously described9 and BACTEC Paeds-Plus in 2013-2015. 
Briefly, at the laboratory, culture bottles were incubated in 
aerobic conventional incubator for the oxoid signal system or 
in the BACTEC 9040 instrument following all manufacturer’s 
instructions and incubated until growth was signaled or for a 
maximum of five days. Bottles that signal growth were 
removed and sub-cultured unto Blood agar, Chocolate agar 
and MacConkey agar. Isolates were identified according to 
standard methods and criteria. Isolates such as K. 
pneumoniae, E. coli, S. aureus and P. aeruginosa were regarded 
as pathogens while most coagulase negative Staphylococci 
and aerobic spore bearers were regarded as contaminants. 
Where there were doubts, the clinical features of the patients 
were factored into the decision making process as to whether 
an isolate was a pathogen or a contaminant. Antibiotic 
susceptibility test was performed using modified Kirby-Buer 
disc diffusion method and interpreted for all according to 
CLSI guidelines. Escherichia coli ATTC 25922, Staphylococcus 
aureus ATTC 25923, and Pseudomonas aeruginosa ATTC 27853 
were used as controls. 
RESULTS 
A total of 1209 blood cultures were processed at the NHA 
medical microbiology laboratory during the 2013-2015 
period. There were 260 blood cultures processed from 
neonates; 21.5% of the total.  Bacteria were isolated in 85 of 
the 260 (32.7%) neonatal cultures while in the 2002 - 2004 
report 
, isolation rate was 22% (Table 1). Contamination rate in the 
present review was 1.5%. The study done 10 years ago did 
not evaluate for contamination.   
Gram positive cocci accounted for 56 of 81 (69%) of isolates 
while it was 49.5% ten years ago. Gram negative bacteria 
were 31% and 51% in the two time periods respectively 
(Table 1).  
 
TABLE 1: BACTERIAL ISOLATES IN NEONATAL SEPSIS 
 2013-2015 2002-2004 p value 
Total Blood cultures 
processed 
1209 1555  
Neonatal blood cultures 
processed 
290 (21.5%) 390 (25.0%) 0.6 
Isolation rate 81 (32.7%) 85 (22%) 0.2 
Contamination rate 4 (1.5%) - - 
Bacterial Isolates during the two study periods 
S. aureus 48 (59.3) 34 (40.0) 0.01 
K. pneumonia 9 (11.1) 37 (43.5) 0.001 
P. aeruginosa 7 (8.6) 4 (4.7) 0.3 
CoNS 5 (6.2) 2 (2.4) 0.3 
E. coli 3 (3.7) 1 (1.2) 0.5 
Enterobacter spp 3 (3.7) - - 
Enterococcus spp 3 (3.7) 4 (4.7) 1.0 
Alkaligenes spp 1 (1.2) - - 
Salmonella spp 1 (1.2) - - 
N. lactamica 1 (1.2) - - 
Acinetobacter spp - 1 (1.2) - 
S. pneumonia - 2 (2.4) - 
 
Gram positive bacteria 56 (69.1) 42 (49.5) 0.01 
Gram negative bacteria 25 (30.9) 43 (50.5) 0.3 
 
Staphylococcus aureus accounted of 59% for isolates from 
newborn in this review but accounted for 40% in the prior 
review while Klebsiella pneumoniae constituted 11.1% as 
against the previous review where it accounted for 43.5% of 
neonatal isolates (table 1 below).  
Decrease in susceptibility of S.aureus to various antibiotics 
was observed from 2002-2004 period to 2013-2015 period as 
follows; Amoxicillin-clavulanate from 85% to 76%, 
Cefuroxime from 45% to 0%, Ciprofloxacin from 71% to 67%; 
Erythromycin from 64% to 30%; Gentamicin from  40% to  
29% and Ceftriaxone from 36%  to 27%. See Figure 1. 
For K. pneumonia isolates susceptibility decreased from 100% 
to 75% for Imipenem, from 15% to 0% for Ceftazidime, 100% 
to 63% for the fluoroquinolones for 2002-2004 and 2013-2015 
respectively. An increase in susceptibility was observed for 








FIGURE 1: SENSITIVITY PROFILE OF STAPHYLOCOCCUS 
AUREUS TO VARIOUS ANTIBIOTICS AT TWO TIME PERIODS 
 
 
FIGURE 2: SENSITIVITY PROFILE OF KLEBSIELLA 












DISCUSSION                                                                                     
The study showed that S. aureus and K. pneumoniae were the 
two dominant aetiologic agents of sepsis in the two periods 
evaluated. However, whereas the gram negative K. 
pneumoniae was the predominant agent in the 2002-2004 
period, the gram positive, S. aureus was the predominant 
organism in the 2013-2015 period. Thus, over one decade the 
organisms causing neonatal sepsis had shifted from a 
predominance of gram negatives to gram positives. Previous 
studies have also established the predominance of gram 
positives in this decade (13-17).  While bacteria are known to 
vary temporally, we postulate other reasons for this shift to 
more S. aureus in particular and consequently gram positive 
bacteria as a group; one postulate is that this may have 
resulted from a change in the type of bacteria colonizing the 
ano-genital region of the mother to mainly staphylococci and 
consequent newborn colonization with these organism; a 
future study assessing the maternal ano-genital colonization 
and newborn colonization with S aureus could answer this 
question. Another postulate is a changing antibiotic exposure 
of the population to groups active mainly against gram 
negative bacteria.   
Similarly, the antibiotic susceptibility pattern changed 
remarkably.  There was an alarming increase in resistance of 
major pathogens to most antibiotics commonly used in the 
management of neonatal sepsis.  This will inadvertently lead 
to negative impact on the pattern of morbidity and mortality 
in the hospital, including resulting in longer hospital stay 
and increased cost of care. If the current trend continues, 
with the looming dryness of antibiotic pipeline, Nigeria will 
be faced with a situation similar to the pre-antibiotic era 
where even minor bacterial infections will be untreatable.  
The NICU/SCBU at the National Hospital Abuja is a vital 
place to initiate antibiotic stewardship and infection control 
programs to mitigate this adverse antibiotic resistance trend. 
Intensive care units have been described as the factories 
where antibiotic resistance genes are created and spread to 
other parts of the hospital and community (18). This 
probably arises from the relatively large amounts of 
antibiotics consumed which in many instances are 
unnecessary or inappropriate. Regular antibiotic 
susceptibility surveillance is necessary to ensure evidence-
based empiric treatment, while definitive treatment must be 
based on individualized testing. Notably, the antibiotics 
Cefuroxime and Gentamicin will be ineffective in the current 
decade as empiric choices for management of neonatal sepsis 
at National Hospital Abuja.  
The isolation of coagulase negative staphylococci in pure 
culture warrants further investigation as to their role as 
agents of neonatal sepsis. They have hitherto been 
considered contaminants in developing countries. Perhaps 
there is a need to report susceptibilities for this group of 
isolates until it is proved that they are not a cause of sepsis in 
developing countries.  
Conclusion 
Continuous local surveillance of bacteria causing invasive 
disease in newborn units and their antibiotic susceptibilities 
is vital in ensuring improved outcomes for neonates. The 
implementation of standard infection control practices could 
also result in reduced incidence of neonatal sepsis at the 
National Hospital Abuja. Antibiotic stewardship as a vital 
part of infection control also needs implementation, and 
could result in decreased acceleration towards resistance or 
even reverse to susceptibility of particular drug classes. 
REFERENCES 
1.  Seale AC, Blencowe H, Manu AA, et al. Estimates 
of possible severe bacterial infection in neonates in 
sub-Saharan Africa, south Asia, and Latin America 
for 2012: a systematic review and meta-analysis. 
Lancet Infect Dis. 2014;14(8):731-741. 
doi:10.1016/S1473-3099(14)70804-7. 
2.  Charles NC, Chuku A, Anazodo NM. Childhood 
mortality in federal medical centre umuahia, South 





3.  Mukhtar-Yola M, Iliyasu Z. A review of neonatal 
morbidity and mortality in Aminu Kano Teaching 
Hospital, northern Nigeria. Trop Doct. 
2007;37(3):130-132. doi:10.1258/004947507781524683. 
4.  Airede AI. Neonatal septicaemia in an African city 
of high altitude. J Trop Pediatr. 1992;38(4):189-191. 
http://www.ncbi.nlm.nih.gov/pubmed/1527816. 
Accessed April 29, 2016. 
5.  Awoala WB, Nnenna TP. Clinico-Bacteriological 
profile of early and late onset sepsis in a tertiary 
hospital in Nigeria. J Med Med Sci. 2012;3(2):107-
111. 
6.  Mavenyengwa RT, Afset JE, Schei B, et al. Group B 
Streptococcus colonization during pregnancy and 
maternal-fetal transmission in Zimbabwe. Acta 
Obstet Gynecol Scand. 2010;89(2):250-255. 
doi:10.3109/00016340903398029. 
7.  Ekanem AD, Anah MU, Udo JJ. The prevalence of 
congenital malaria among neonates with suspected 
sepsis in Calabar, Nigeria. Trop Doct. 2008;38(2):73-
76. doi:10.1258/td.2007.005274. 
8.  Ojukwu JU, Abonyi LE, Ugwu J, Orji IK. Neonatal 
septicemia in high risk babies in South-Eastern 
Nigeria. J Perinat Med. 2006;34(2):166-172. 
doi:10.1515/JPM.2006.030. 
9.  Iregbu KC, Elegba OY, Babaniyi IB. Bacteriological 
profile of neonatal septicaemia in a tertiary 
hospital in Nigeria. Afr Health Sci. 2006;6(3):151-
154. doi:10.5555/afhs.2006.6.3.151. 
10.  Mokuolu AO, Jiya N, Adesiyun OO. Neonatal 
septicaemia in Ilorin: bacterial pathogens and 
antibiotic sensitivity pattern. Afr J Med Med Sci. 
2002;31(2):127-130. 
http://www.ncbi.nlm.nih.gov/pubmed/12518907. 
Accessed June 21, 2016. 
11.  Adejuyigbe EA, Ako-Nai AK, Adisa B. Bacterial 
isolates in the sick young infant in Ile-Ife, Nigeria. 
J Trop Pediatr. 2004;50(6):323-327. 
doi:10.1093/tropej/50.6.323. 
12.  Ako-Nai AK, Adejuyigbe EA, Ajayi FM, Onipede 
AO. The bacteriology of neonatal septicaemia in 
Ile-Ife, Nigeria. J Trop Pediatr. 1999;45(3):146-151. 
http://www.ncbi.nlm.nih.gov/pubmed/10401192. 
Accessed April 29, 2016. 
13.  Microsoft Word - Awoniyi et al. Pdf.doc - 
article1380275530_Awoniyi et al.pdf. 
http://www.academicjournals.org/article/article1380
275530_Awoniyi et al.pdf. Accessed April 9, 2016. 
14.  Meremikwu MM, Nwachukwu CE, Asuquo AE, 
Okebe JU, Utsalo SJ. Bacterial isolates from blood 
cultures of children with suspected septicaemia in 
Calabar, Nigeria. BMC Infect Dis. 2005;5(1):110. 
doi:10.1186/1471-2334-5-110. 
15.  Ogunlesi TA, Ogunfowora OB, Osinupebi O, 
Olanrewaju DM. Changing trends in newborn 
sepsis in Sagamu, Nigeria: bacterial aetiology, risk 
factors and antibiotic susceptibility. J Paediatr 
Child Health. 2011;47(1-2):5-11. doi:10.1111/j.1440-
1754.2010.01882.x. 
16.  Antia-Obong OE, Utsalo SJ, Udo JJ, Udo KT. 
Neonatal septicaemia in Calabar, Nigeria. Cent Afr 
J Med. 1992;38(4):161-165. 
http://www.ncbi.nlm.nih.gov/pubmed/1394397. 
Accessed May 3, 2016. 
17.  Mugalu J, Nakakeeto MK, Kiguli S, Kaddu-
Mulindwa DH. Aetiology, risk factors and 
immediate outcome of bacteriologically confirmed 
neonatal septicaemia in Mulago hospital, Uganda. 
Afr Health Sci. 2006;6(2):120-126. 
doi:10.5555/afhs.2006.6.2.120. 
18.  Brusselaers N, Vogelaers D, Blot S. The rising 
problem of antimicrobial resistance in the 
intensive care unit. Ann Intensive Care. 2011;1:47. 
doi:10.1186/2110-5820-1-47. 
 
 
